ScholarIQanswers from OpenAlex & ORCID
Gerd R Burmester
ResearcherPublications, citations & collaboration network
Gerd R Burmester is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gerd R Burmester have?
ScholarIQindexed works
Gerd R Burmester has 961 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gerd R Burmester have?
ScholarIQcitation count
Gerd R Burmester has 65,038 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gerd R Burmester?
ScholarIQh-index
Gerd R Burmester has an h-index of 116 in OpenAlex.
What is the i10-index of Gerd R Burmester?
ScholarIQi10-index
Gerd R Burmester has an i10-index of 428 in OpenAlex.
What is the ORCID of Gerd R Burmester?
ScholarIQorcid
The ORCID for Gerd R Burmester is on the source record.
What is the OpenAlex record for Gerd R Burmester?
ScholarIQopenalex
The OpenAlex for Gerd R Burmester is on the source record.
What are the most-cited papers on Gerd R Burmester?
ScholarIQmost cited works
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham, Neal S. Birnbaum, Gerd R Burmester, Vivian P. Bykerk, Marc D. Cohen, Bernard Combe, Karen H. Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna M. W. Hazes, Kathryn Hobbs, T. Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K. Kvien, Timothy Laing, Philip J. Mease, Henri A. Ménard, Larry W. Moreland, Raymond L. Naden, Theodore Pincus, Josef S Smolen, Ewa Stanisławska‐Biernat, Deborah Symmons, Paul P. Tak, Katherine S. Upchurch, Jiří Vencovský, Frederick Wolfe, Gillian Hawker
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde
Rheumatoid arthritis
Josef S Smolen, Daniel Aletaha, Anne Barton, Gerd R Burmester, Paul Emery, Gary S. Firestein, Arthur Kavanaugh, Iain B. McInnes, Daniel H. Solomon, Vibeke Strand, Kazuhiko Yamamoto
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Simone Gorter, Rachel Knevel, J. Nam, Monika Schoels, Daniel Aletaha, Maya H Buch, Laure Gossec, T. Huizinga, J. W. J. Bijlsma, Gerd R Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan J. Gómez‐Reino, Marios Kouloumas, Tore K Kvien, E. Martín‐Mola, Iain B. McInnes, Karel Pavelká, Piet L. C. M. van Riel, M. Scholte, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin Winthrop, John B. Wong, A. Zink, Désirée van der Heijde